Klinefelter Syndrome

Slide 1 · Klinefelter syndrome

Sex-chromosome aneuploidy, mechanisms, testicular pathology, and clinical effects

Robbins-based pathology lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Relate a supernumerary X chromosome to a variable male phenotype.

Explain X-inactivation escape, SHOX dosage, and androgen receptor effects.

Recognize characteristic testicular changes and gonadotropin patterns.

Connect infertility and systemic associations to clinicopathologic findings.

Slide 3 · Core definition: Extra X and male hypogonadism

Klinefelter syndrome is a sex-chromosome disorder affecting individuals with a Y chromosome and at least two X chromosomes.

Male hypogonadism is a defining pathophysiologic feature.

The classic chromosome complement is 47,XXY.

Phenotype varies substantially among affected individuals.

Slide 4 · Genotype is not the same as phenotype

Chromosomal description

Supernumerary X chromosome in the presence of a Y chromosome.

Classic 47,XXY or a mosaic cell population.

Clinical expression

Hypogonadism and impaired spermatogenesis are central.

Body habitus, secondary sexual characteristics, and comorbidity vary.

Slide 5 · Why sex-chromosome imbalances are relatively tolerated

Most genes on all but one X chromosome are inactivated.

The Y chromosome contains less genetic material than an autosome.

Nevertheless, genes that escape X-inactivation produce residual dosage effects.

Reproductive development and fertility remain particularly vulnerable.

Slide 6 · Normal male versus classic Klinefelter complement

Usual male: 46,XY

X

Y

Klinefelter: 47,XXY

X

X

Y

The additional X chromosome is the cytogenetic distinction illustrated here.

Slide 7 · Y chromosome: Determinant of testicular development

The presence of a Y chromosome generally drives male sex determination.

SRY is located on the short arm of the Y chromosome.

The Y chromosome also carries genes relevant to spermatogenesis.

An additional X modifies development despite the Y chromosome.

Slide 8 · Two interacting pathogenetic axes

Extra X chromosome

Escape from X silencing

Increased gene dosage

Gene-dosage effects act alongside testicular dysfunction to produce the clinical phenotype.

Hypogonadism is a second major axis, not simply a synonym for extra X dosage.

Slide 9 · Frequency and underrecognition

An incidence of approximately 1 in 660 live male births.

This as an underestimate.

Mild phenotypes may not lead to clinical assessment.

Ascertainment therefore favors individuals with more conspicuous manifestations.

Slide 10 · Why diagnosis commonly occurs after childhood

Early childhood

Pubertal endocrine change

Recognizable hypogonadism

Before puberty, characteristic androgen-dependent clinical signs may be absent or subtle.

Clinical recognition and the presence of the genetic condition are separate issues.

Slide 11 · Classic karyotype: 47,XXY

X

X

Y

47,XXY

Schematic representation: Two X chromosomes and one Y chromosome

Slide 12 · Meiotic nondisjunction produces an extra X

Parental meiosis

Sex-chromosome segregation error

XXY conceptus

Abnormal chromosome segregation during gamete formation yields the classic complement.

Slide 13 · Maternal and paternal origins

Maternal contribution

A segregation error in oogenesis may transmit the supernumerary X.

The parental origin does not create a reliably distinct phenotype.

Paternal contribution

A segregation error in spermatogenesis may likewise produce 47,XXY.

First-meiotic-division errors from both parents.

Slide 14 · Maternal age as a risk factor

Advanced maternal age is listed as a risk factor in the Robbins section.

This association concerns nondisjunction risk, not a distinct subtype of the disease.

The genetic outcome is an extra sex chromosome; Phenotype still varies afterward.

Slide 15 · Mosaic form: 46,XY / 47,XXY

Cell line A

X

Y

Cell line B

X

X

Y

Mosaicism refers to more than one chromosomal cell population

Slide 16 · Mosaicism modifies chromosomal composition

Mosaic patients contain distinct cell populations with different complements.

A frequent reported pattern combines 46,XY and 47,XXY cells.

The tested tissue and its cell populations matter when interpreting mosaicism.

Karyotypic heterogeneity is one contributor to overall clinical variability.

Slide 17 · Structural-X variants beyond simple XXY

The textbook also describes rare cell lines bearing structurally abnormal X chromosomes.

An isochromosome involving the X long arm is given as an example.

These are chromosomal variants, not evidence that all cases are simple 47,XXY.

Karyotype interpretation should distinguish number from structure.

Slide 18 · Lyonization: One X largely remains active

Two X chromosomes

XIST RNA coating

Relative silencingof one X

Some loci escape inactivation, so dosage compensation is incomplete.

Slide 19 · X-inactivation provides partial dosage compensation

In cells with multiple X chromosomes, all but one undergo X-inactivation.

Silencing occurs early in embryogenesis and is maintained in descendant cells.

This produces a functional mosaic of maternal-X and paternal-X activity.

Silencing is incomplete at some loci, explaining persistent dosage effects.

Slide 20 · Barr body: The inactive X chromosome

Nucleus

Condensed inactive X(Barr body)

Schematic: Condensed nuclear chromatin, not a diagnostic micrograph

Slide 21 · XIST is a noncoding RNA with a silencing role

XIST is transcribed at the X-inactivation center.

The RNA coats the chromosome from which it is expressed.

Chromatin changes and DNA methylation contribute to silencing.

The active X does not express XIST in the same way.

Slide 22 · X-inactivation does not silence every locus

One X remains active

Other X mostly silenced

Escape genes expressed

Genes that escape Lyonization can have increased copy-dependent output in XXY cells.

Slide 23 · Pseudoautosomal regions escape silencing

The ends of the X and Y chromosomes share homologous pseudoautosomal regions.

These regions recombine during meiosis.

Their genes commonly escape X-inactivation.

Additional active copies can influence somatic development.

Slide 24 · SHOX dosage helps explain tall stature

Extra X chromosome

Extra active SHOX copy

Increased long-bone growth

Additional SHOX dosage as a probable contributor to tall stature and long legs.

Proposed genotype–phenotype link; Body proportions are not universal.

Slide 25 · Extra X alters more than X-linked transcription

The source states that many upregulated transcripts lie outside the X chromosome.

The supernumerary X can influence expression of autosomal genes indirectly.

Gene-dosage effects therefore need not be restricted to X-linked proteins.

This is a genomic regulatory effect, distinct from testicular hormone deficiency.

Slide 26 · The androgen receptor is X-linked

The androgen receptor gene is located on the X chromosome.

The receptor mediates target-cell responses to testosterone.

Polymorphic CAG trinucleotide repeats influence receptor activity.

Hormone concentration alone may not capture the tissue androgen response.

Slide 27 · CAG-repeat length and receptor sensitivity

Shorter androgen-receptor CAG repeat

Longer androgen-receptor CAG repeat

Greater sensitivity to a given androgen dose

Lower sensitivity to a given androgen dose

Potentially stronger receptor-mediated response

Potentially weaker receptor-mediated response

Source relationship: relative functional sensitivity

Repeat length is not itself a clinical diagnosis

Slide 28 · Preferential inactivation may modify androgen effects

Preferential inactivation of the X carrying the shorter CAG-repeat androgen receptor allele.

The expressed receptor may therefore be comparatively less androgen-sensitive.

At lower testosterone concentrations, this may amplify the hypogonadal phenotype.

The textbook associates this model with some genital-development features.

Slide 29 · Integrated molecular-to-hormonal phenotype

Extra X gene dosage

Testicular insufficiency

Modified androgen action

Gene dosage, gonadal impairment, and receptor sensitivity jointly contribute to variable findings.

Conceptual integration of textbook-described contributors.

Slide 30 · Hypogonadism becomes clearer around puberty

Puberty normally increases demand for testosterone-dependent development.

Klinefelter syndrome may become conspicuous when androgen-dependent changes are inadequate.

Presentation before puberty is less common.

Timing of recognition does not determine the origin of the chromosome abnormality.

Slide 31 · Body proportions and skeletal phenotype

Typical pattern

Tall or elongated body habitus.

Relatively long legs with increased sole-to-pubic-bone length.

SHOX dosage is a proposed molecular explanation.

Interpretive caution

Neither height nor limb length is diagnostic alone.

Physical attributes vary substantially.

Karyotype and gonadal phenotype are more informative together.

Slide 32 · Small testes are a central morphological finding

The source describes testes as small and atrophic.

Atrophy reflects loss or failed maturation of the seminiferous tubular compartment.

Testicular size connects cytogenetic disease with endocrine and reproductive failure.

Other somatic characteristics may be inconspicuous despite gonadal pathology.

Slide 33 · Incomplete masculinization of secondary characteristics

Some patients lack the typical deepening of the voice.

Beard development and male-pattern pubic hair may be reduced.

The penis may be relatively small in affected individuals.

These are examples of variable androgen-dependent features, not universal signs.

Slide 34 · Gynecomastia reflects hormonal balance

Reduced androgen effect

Altered estrogen : Androgen ratio

Breast tissue response

Estradiol levels may be higher while testosterone is variably reduced; The balance influences feminization.

The precise mechanism responsible for higher estradiol is described as unknown.

Slide 35 · Cognitive phenotype: Avoid overgeneralization

Cognitive performance ranges from average to below average description.

Modest difficulties may involve verbal skills.

Reading and language comprehension are specifically mentioned.

The chromosomal diagnosis does not predict uniform intellectual impairment.

Slide 36 · Phenotypic variability is fundamental

An individual may not show the complete traditional constellation of findings.

Degree of hypogonadism differs between affected persons.

X-inactivation patterns, mosaicism, and receptor variation offer plausible modifiers.

The source emphasizes hypogonadism as the most consistent feature.

Slide 37 · Normal-appearing seminiferous tubule: Conceptual reference

Patent lumen with cellular rim

Schematic only: Provides architectural context for the abnormal patterns.

Slide 38 · Atrophic tubule with hyaline replacement

Hyalinized tubular ghost

The source describes pink, hyaline, collagenous remnants when atrophy is advanced.

Slide 39 · Mixed preservation and atrophy

Relatively preserved

Atrophic / hyalinized

Apparently normal tubules interspersed with atrophic tubules in some patients.

Slide 40 · Primitive tubules may fail to form a lumen

Primitive solid cellular cord

Embryonic-appearing cords may remain without lumen formation or mature spermatogenesis.

Slide 41 · Tubular pathology can be heterogeneous

Complete tubular loss with hyaline ghosts is one described pattern.

Patchy preserved and atrophic tubules represent another pattern.

Primitive, non-lumen-forming cords are also reported.

These patterns converge on diminished mature sperm production.

Slide 42 · Leydig cells may appear relatively prominent

Germ cell loss

Tubule crowding and gonadotropin rise

Apparent Leydig-cell prominence

The textbook attributes prominence partly to the reduction of surrounding tubular components.

This does not establish that increased Leydig-cell function compensates effectively.

Slide 43 · How testicular changes impair fertility

Tubular atrophy

Reduced spermatogenesis

Male infertility

The principal reproductive consequence is reduced production of mature sperm.

Slide 44 · Infertility is a major route to recognition

Klinefelter syndrome is an important genetic cause of male infertility.

Testicular damage can impair spermatogenesis even when somatic signs are subtle.

The degree of tubular preservation may vary histologically.

A fertility presentation should prompt integration of gonadal and chromosomal findings.

Slide 45 · Gonadotropins are characteristically elevated

The source describes elevated plasma gonadotropin concentrations.

Follicle-stimulating hormone (FSH) is particularly consistently increased.

The endocrine pattern accompanies testicular dysfunction.

Klinefelter syndrome is therefore a form of primary gonadal failure.

Slide 46 · Testosterone is variably reduced

Testosterone concentration is not uniformly low in all cases.

The degree of androgen deficiency influences clinical expression.

Some physical signs are consequences of reduced androgen action.

The hormone profile must be interpreted alongside the testes and karyotype.

Slide 47 · Estradiol and androgen balance

Mean estradiol concentrations are reported as higher in affected individuals.

The mechanism remains unknown.

The estrogen-to-testosterone balance modifies the degree of feminization.

Avoid attributing a single proven biochemical pathway without further evidence.

Slide 48 · Endocrine, tissue, and clinical integration

Testicular failure

Elevated FSH; Variable testosterone

Reproductive and somatic features

Tubular atrophy, impaired spermatogenesis, and altered sexual characteristics are linked findings.

The endocrine flow is a conceptual causal synthesis, not a diagnostic cutoff algorithm.

Slide 49 · Clinicopathologic connections

Finding

Source-based interpretation

Elevated FSH

Testicular dysfunction with a hypergonadotropic pattern

Small atrophic testes

Tubular impairment and reduced germ cell function

Variable testosterone

Heterogeneous androgen-dependent manifestations

Reduced spermatogenesis

Potential infertility

Gynecomastia

Altered sex-steroid balance

Slide 50 · Metabolic associations

Increased type 2 diabetes frequency.

Metabolic syndrome and insulin resistance are also described.

These are comorbid associations rather than defining diagnostic criteria.

Clinical assessment should not focus exclusively on infertility.

Slide 51 · Skeletal complications reflect sex-steroid imbalance

Osteoporosis is more frequent account.

Fracture risk is correspondingly increased.

Sex-hormonal imbalance is the suggested contributing mechanism.

Skeletal consequences illustrate the systemic impact of hypogonadism.

Slide 52 · Cardiovascular associations reported by Robbins

Congenital heart disease is reported more often.

Mitral valve prolapse is highlighted.

Atrial and ventricular septal defects are also mentioned.

These associations are not required to recognize the syndrome.

Slide 53 · Extragonadal germ-cell tumor association

An increased risk of extragonadal germ-cell tumors.

The mediastinum is the emphasized site.

Mediastinal teratoma is given as an example.

This is an important neoplastic association, not a diagnostic requirement.

Slide 54 · Additional breast and autoimmune associations

The source describes a higher frequency of breast cancer.

Autoimmune disorders, particularly systemic lupus erythematosus, are also reported more often.

These associations should be separated from the direct gonadal histopathology.

Risk associations do not mean each patient will develop these conditions.

Slide 55 · Typical manifestations: Direct effects and associations

Core disease expressions

Systemic associations

Small atrophic testes; reduced spermatogenesis

Type 2 diabetes / metabolic syndrome

Elevated FSH; variable testosterone

Osteoporosis and fractures

Variable virilization; long legs; gynecomastia

Congenital cardiac abnormalities

Infertility

Mediastinal germ-cell tumors; breast cancer; autoimmunity

Slide 56 · Application case: Puberty and hypogonadism

A male adolescent has disproportionately long legs, small testes, and incomplete development of secondary sexual characteristics.

Which chromosomal complement would unify the phenotype?

Classic 47,XXY is a leading mechanistic possibility; Chromosomal testing would establish the complement.

Slide 57 · Application case: Infertility and tubular atrophy

An adult with reduced sperm production is found to have small testes, increased FSH, and variable testosterone concentration.

What links the reproductive and endocrine findings?

Primary testicular dysfunction with seminiferous tubular impairment links these observations.

Slide 58 · Application case: Interpreting testicular architecture

A conceptual pathology drawing shows seminiferous structures replaced by hyaline collagenous remnants; Other tubules are better preserved.

Why can different tubules have different appearances?

Heterogeneous tubular atrophy, ranging from patchy preservation to hyaline ghosts.

Slide 59 · Klinefelter and Turner: Sex-chromosome contrast

Feature

Klinefelter syndrome

Turner syndrome

Representative karyotype

47,XXY

45,X

Gonadal phenotype

Male hypogonadism

Female hypogonadism

Sex-chromosome imbalance

Supernumerary X

Loss of all or part of an X

Common theme

Abnormal gene dosage and fertility

Abnormal gene dosage and fertility

Slide 60 · Pitfalls in interpreting phenotype

Do not exclude an extra X chromosome solely because body habitus appears typical.

Do not assume severe cognitive impairment from karyotype alone.

Do not equate a variable testosterone level with absence of testicular pathology.

Do not infer the complete karyotype from a single clinical feature.

Slide 61 · Synthesis: From chromosome complement to tissue changes

47,XXY or mosaic cell lines

Incomplete dosage compensation

Gonadal dysfunction

The characteristic outcome is hypogonadism, with broad variation in somatic manifestations.

Reduced spermatogenesis, elevated FSH, and tubular atrophy link mechanism to pathology.

Slide 62 · Major clinicopathologic conclusions

An additional X chromosome acts through incompletely silenced genes and altered regulation.

SHOX dosage contributes to body proportions; Androgen-receptor variation can modify response.

Testicular tubular pathology underlies impaired sperm formation and a hypergonadotropic pattern.

Clinical expression and systemic associations are heterogeneous.

Slide 63 · Source and limits of this lecture

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026).

Chapter 5, “Genes and Human Diseases”: sex-chromosome disorders and Klinefelter syndrome.

Figures in this lecture are original, simplified editable schematics; no histological specimen images are reproduced.

Diagnostic algorithms, treatment recommendations, and changing practice guidelines were outside the supplied excerpt.